Nanog在多种癌组织中的表达及临床意义

韩敬华 张飞 武冰 张海嫦 王宇晴 田然 宋伟杰 牛瑞芳

韩敬华, 张飞, 武冰, 张海嫦, 王宇晴, 田然, 宋伟杰, 牛瑞芳. Nanog在多种癌组织中的表达及临床意义[J]. 中国肿瘤临床, 2012, 39(1): 10-13. doi: 10.3969/j.issn.1000-8179.2012.01.003
引用本文: 韩敬华, 张飞, 武冰, 张海嫦, 王宇晴, 田然, 宋伟杰, 牛瑞芳. Nanog在多种癌组织中的表达及临床意义[J]. 中国肿瘤临床, 2012, 39(1): 10-13. doi: 10.3969/j.issn.1000-8179.2012.01.003
Jinghua HAN, Fei ZHANG, Bing WU, Haichang ZHANG, Yuqing WANG, Ran TIAN, Weijie SONG, Ruifang NIU. Expression and Clinical Significance of Nanog in Tissue of Several Cancer Types[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(1): 10-13. doi: 10.3969/j.issn.1000-8179.2012.01.003
Citation: Jinghua HAN, Fei ZHANG, Bing WU, Haichang ZHANG, Yuqing WANG, Ran TIAN, Weijie SONG, Ruifang NIU. Expression and Clinical Significance of Nanog in Tissue of Several Cancer Types[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(1): 10-13. doi: 10.3969/j.issn.1000-8179.2012.01.003

Nanog在多种癌组织中的表达及临床意义

doi: 10.3969/j.issn.1000-8179.2012.01.003
基金项目: 

国家自然科学基金 81071731

教育部“长江学者和创新团队发展计划”项目 IRT1076

详细信息
    通讯作者:

    牛瑞芳  niurf1982@yahoo.com.cn

Expression and Clinical Significance of Nanog in Tissue of Several Cancer Types

Funds: 

the National Natural Science Foundation of China 81071731

the Changjiang Scholars and Innovative Research Team Development Plan of the Ministry of Education IRT1076

More Information
  • 摘要:   目的   分析Nanog在非小细胞肺癌(NSCLC)、胃腺癌、食管鳞状细胞癌中的表达特点及规律,探讨Nanog的表达在肿瘤发生、发展中的意义及其与肿瘤干细胞的关系。   方法   采用实时荧光定量PCR法分别检测78例NSCLC及其中10例肺癌患者的癌旁组织、39例胃腺癌及其中10例胃腺癌患者的癌旁组织和35例食管鳞癌及其中10例食管鳞癌患者的癌旁组织中Nanog的相对表达情况。   结果   NSCLC、胃腺癌和食管鳞癌组织中Nanog相对表达量明显高于对应的癌旁组织,且肺癌和胃腺癌与其对应的癌旁组织之间差异具有统计学意义(P < 0.05)。肺癌中Nanog的相对表达量与患者的临床分期和肿瘤组织学类型有关(P < 0.05);胃腺癌组织中,Nanog的相对表达量与胃腺癌的临床分期、性别有关(P < 0.05);食管鳞癌组织中,Nanog的相对表达量与淋巴结转移、临床分期有关(P < 0.05)。   结论   在肿瘤进展过程中,Nanog的表达与肿瘤的临床分期和淋巴结转移有关,提示Nanog的表达在腺癌的发生、发展中可能具有一定意义。

     

  • 表  1  各种癌组织及其癌旁组织中Nanog相对表达量

    Table  1.   Relative expression of Nanog in tissue of several cancer types and corresponding adjacent tissue

    表  2  肺癌组织中Nanog相对表达量与临床病理特征之间的关系

    Table  2.   Relationship between Nanog expression and clinicopathologic features of NSCLC

    表  3  肺癌不同临床分期中Nanog相对表达量与癌旁组织之间的差异

    Table  3.   Relative expression of Nanog among NSCLC and adjacent tissue of different clinical stages

    表  4  胃腺癌组织中Nanog相对表达量与临床病理特征之间的关系

    Table  4.   Relationship between Nanog expression and clinicogathologic features of gastric adenocarcinoma

    表  5  食管鳞癌组织中Nanog相对表达量与临床病理特征之间的关系

    Table  5.   Relationship between Nanog expression and clinicopathologic features of esophageal squamous cell carcinoma

  • [1] 邹爱梅, 吴爱兵, 黄维甄, 等. 肺癌A549细胞株中ALDH1+细胞的生物学功能研究[J]. 中国肿瘤临床, 2011, 38(14): 817-821. doi: 10.3969/j.issn.1000-8179.2011.14.002
    [2] Jordan CT, Guzman ML, Noble M. Cancer stem cells[J]. N Engl J Med, 2006, 355(12): 1253-1261. doi: 10.1056/NEJMra061808
    [3] Lobo NA, Shimono Y, Qian D, et al. The biology of cancer stem cells[J]. Annu Rev Cell Dev Biol, 2007, 23: 675-699. doi: 10.1146/annurev.cellbio.22.010305.104154
    [4] Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea--a paradigm shift[J]. Cancer Res, 2006, 66(4): 1883-1890. doi: 10.1158/0008-5472.CAN-05-3153
    [5] Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors [J]. Cancer Res, 2003, 63(9): 2244-2250.
    [6] Ezeh UI, Turek PJ, Reijo RA, et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma[J]. Cancer, 2005, 104(10): 2255-2265. doi: 10.1002/cncr.21432
    [7] Hoei-Hansen CE, Almstrup K, Nielsen JE, et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours[J]. Histopathology, 2005, 47(1): 48-56. doi: 10.1111/j.1365-2559.2005.02182.x
    [8] Zbinden M, Duquet A, Lorente-Trigos A, et al. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53[J]. EMBO, 2010, 29(15): 2659-2674. doi: 10.1038/emboj.2010.137
    [9] Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859): 105-111. doi: 10.1038/35102167
    [10] Lee TK, Castilho A, Cheung VC, et al. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation[J]. cell Stem Cell, 2011, 9(1): 50-63. doi: 10.1016/j.stem.2011.06.005
    [11] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663-676. doi: 10.1016/j.cell.2006.07.024
    [12] Wang SH, Tsai MS, Chiang MF, et al. A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells[J]. Gene Expr Patterns, 2003, 3(1): 99-103. doi: 10.1016/S1567-133X(03)00005-X
    [13] 柳霞, 龙梅, 蒋晖, 等. 人Nanog基因的克隆及其在COS-7L细胞中的表达[J]. 细胞与分子免疫学杂志, 2004, 20(4): 495-498. doi: 10.3321/j.issn:1007-8738.2004.04.033
  • 加载中
表(5)
计量
  • 文章访问数:  47
  • HTML全文浏览量:  11
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-10-18
  • 修回日期:  2011-12-14

目录

    /

    返回文章
    返回